FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Details Standardized Approach to Drug Safety Signal Detection

A new CDER Office of New Drugs webinar discusses the development and use of OND Custom Medical Queries to identify potential safety signals during rev...

latest-news-card-1
Medical Devices

Require IDE for Venas MicroAngioscope: Petition

Harmed Americans for Reform in Medical Device Safety petitions FDA to require an IDE for the Vena MicroAngioscope and take other steps to determine if...

latest-news-card-1
Human Drugs

4 CGMP Violations in Huons Inspection

FDA warns South Koreas Huons Co. about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1

FDA Leadership Upheaval Yields Uncertainty: Post

A Skadden Insights post raises the concern of FDA-regulated companies caused by the significant leadership changes at the agency.

latest-news-card-1
Medical Devices

FDA Issues Early Alert on Abiomed Impella Introducer Kits

FDA issues an early alert warning healthcare providers about a potentially high-risk device issue involving introducer kits used with Impella heart pu...

latest-news-card-1
Human Drugs

FDA Bought Unapproved New Drugs on Amazon

FDA warns Amazon it is marketing unapproved new drugs on its Web site.

latest-news-card-1
FDA General

Gottlieb Praises Clinical Trial Initiative; Calls for FDA Career Leadership

Former FDA commissioner Scott Gottlieb supports the agency's newly announced initiative to accelerate early-stage clinical trials, arguing that the p...

Human Drugs

Jubilant HollisterStier CGMP Issues

FDA warns Canadas Jubilant HollisterStier General Partnership about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

Nicotine Dependence NDA Gets Complete Response Letter

FDA sends Achieve Life Sciences a Complete Response Letter on its NDA for cytisinicline as a treatment for nicotine dependence.

latest-news-card-1
Human Drugs

Pharmaneek Inspection Form FDA-483 Out

FDA releases the form FDA-483 with two observations from an inspection at the Pharmaneek non-sterile drug manufacturing facility in Indianapolis, IN.